Why Big Pharma's $1 Billion Bet to Prevent a Bacterial Pandemic Matters for You

Why Big Pharma's $1 Billion Bet to Prevent a Bacterial Pandemic Matters for You

Last week, over 20 top drugmakers announced the launch of the AMR Action Fund. Key investors in the AMR Action Fund include Pfizer (NYSE: PFE), Roche (OTC: RHHBY), Eli Lilly (NYSE: LLY), Merck (NYSE: MRK), and Johnson & Johnson (NYSE: JNJ).